Back to PT-141 (Bremelanotide)
PT-141 (Bremelanotide) Dosage Guide
Complete dosing protocol, reconstitution steps, and interactive calculator for PT-141 (Bremelanotide).
Dosing & Reconstitution Guide
The FDA-approved dose is 1.75 mg via subcutaneous injection before anticipated sexual activity. All other use cases are investigational or off-label.
Standard / Gradual Approach
10mg VialadvancedPhaseDoseVolume
Weeks 1–8500 mcg15 units (0.15 mL)
Weeks 9–121000 mcg30 units (0.30 mL)
Weeks 13–161500 mcg45 units (0.45 mL)
Protocol Summary
Subcutaneous (SQ): Use as needed ~45 minutes before sexual activity; max 1x per 24h · Dose range 0.75–1.75 mg with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
SubQ Injection
Use as needed, max once per day. Not intended for continuous daily use. Effects peak 45–90 min post-injection.
🧪 Quick Start
Vial Size
10 mg
BAC Water
3 mL
Concentration
3300 mcg/unit
Starting Dose
500 mcg (15 units (0.15 mL))
Maintenance Dose
1500 mcg (45 units (0.45 mL))
🧮 Dose Calculator
Concentration
33.3
mcg/unit
Draw Volume
15
units (0.150 mL)
For a 500 mcg dose, draw 15 units on a U-100 insulin syringe